Minhee Won - RTOG Foundation Statistics and Data Management Center, American College of Radiology

基本信息

浏览量：97

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 91 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

Molecular Classification to Refine Surgical and Radiotherapeutic Decision-Making in Meningioma

Justin Z Wang,Vikas Patil,Alexander P Landry,Chloe Gui,Andrew Ajisebutu,Jeff Liu,Olli Saarela,Stephanie L Pugh,Minhee Won,Zeel Patel,Rebeca Yakubov,Ramneet Kaloti,

Nature medicine (2024)

引用0浏览0WOSNATURE引用

NRG-BN002: Phase I Study of Ipilimumab, Nivolumab, and the Combination in Patients with Newly Diagnosed Glioblastoma

Andrew E. Sloan,Kathryn Winter,Mark R. Gilbert,Kenneth Aldape,Serah Choi,Patrick Y. Wen,Nicholas Butowski,Fabio M. Iwamoto,Raju R. Raval,Alfredo D. Voloschin,Carlos Kamiya-Matsuoka,Minhee Won,

NEURO-ONCOLOGYno. 9 (2024): 1628-1637

引用0浏览0WOS引用

Nrg oncology study bn007: randomized phase ii/iii trial of ipilimiumab (ipi) plus nivolumab (nivo) vs. temozolomide (tmz) in mgmt-unmethylated (umgmt) newly diagnosed glioblastoma (ngbm)

Andrew Lassman,Mei-Yin Polly,Fabio Iwamoto,Andrew Sloan,Tony Wang,Kenneth Aldape,Jeffrey Wefel,Vinai Gondi, Alonson Gutierrez,Mohammed Manasawala, Mark Gilbert,Erik Sulman,

NEURO-ONCOLOGY (2023)

引用0浏览0引用

PL02.3.A NRG ONCOLOGY STUDY BN007: RANDOMIZED PHASE II/III TRIAL OF IPILIMIUMAB (IPI) PLUS NIVOLUMAB (NIVO) VS. TEMOZOLOMIDE (TMZ) IN MGMT-UNMETHYLATED (UMGMT) NEWLY DIAGNOSED GLIOBLASTOMA (NGBM)

Andrew B. Lassman, Mei‐Yin C. Polley,Fabio Iwamoto,Andrew E. Sloan,Tony J. C. Wang,Kenneth Aldape, J.S. Wefel,Vinai Gondi,Alonso N. Gutiérrez,Mohammed Manasawala,Mark R. Gilbert,Erik P. Sulman,

Neuro-oncologyno. Supplement_2 (2023): ii2-ii2

引用0浏览0引用

TARGETED GENE EXPRESSION PROFILING PREDICTS MENINGIOMA OUTCOMES AND RADIOTHERAPY RESPONSES

William Chen,Abrar Choudhury,Mark W. Youngblood,Mei-Yin Polly,Calixto-Hope Lucas,Kanish Mirchia,Sybren Maas,Abigail Suwala,Minhee Won,James Bayley,Akdes Harmanci,Arif Harmanci,

Neuro-Oncologyno. Supplement_5 (2023)

引用1浏览0引用

Ctim-18. nrg oncology study bn007: randomized phase ii/iii trial of ipilimiumab (ipi) plus nivolumab (nivo) vs. temozolomide (tmz) in mgmt-unmethylated (umgmt) newly diagnosed glioblastoma (ngbm)

Andrew B. Lassman,Mei-Yin Polly,Fabio Iwamoto,Andrew E. Sloan,Tony Wang,Kenneth Aldape,Jeffrey S. Wefel,Vinai Gondi,Alonso N. Gutiérrez,Mohammed Manasawala,Mark R. Gilbert,Erik P. Sulman,

Neuro-Oncologyno. Supplement_5 (2023): v65-v65

引用0浏览0引用

HIGHER VINCRISTINE DOSES CORRELATE WITH LONGER OVERALL SURVIVAL: A POST-HOC ANALYSIS OF PARTICIPANTS RECEIVING PCV ON RTOG 9402

Laura Donovan,Mei-Yin Polly,J. Gregory Cairncross,Andrew Lassman,Fabio Iwamoto,Igor Barani,Luis Souhami,Henry C. Pitot,Barbara Fisher,Maria Werner-Wasik,Jean-Paul Bahary,Anthony Whitton,

NEURO-ONCOLOGY（2023）

引用0浏览0引用

Supplementary Methods, Supplementary Tables 1 through 7, and Supplementary Figures 1 through 7 from Ibrutinib Unmasks Critical Role of Bruton Tyrosine Kinase in Primary CNS Lymphoma

Christian Grommes,Alessandro Pastore,Nicolaos Palaskas, Sarah S. Tang,Carl Campos,Derrek Schartz,Paolo Codega,Donna Nichol,Owen Clark,Wan-Ying Hsieh,Dan Rohle,Marc Rosenblum,

crossref（2023）

引用0浏览0引用

NRG/RTOG 0837: Randomized, Phase II, Double-Blind, Placebo-Controlled Trial of Chemoradiation with or Without Cediranib in Newly Diagnosed Glioblastoma

Tracy T. Batchelor,Minhee Won,Arnab Chakravarti,Costas G. Hadjipanayis,Wenyin Shi,Lynn S. Ashby,Volker W. Stieber,H. Ian Robins,Heidi J. Gray,Alfredo Voloschin,John B. Fiveash,Clifford G. Robinson,

Neuro-Oncology Advancesno. 1 (2023)

引用0浏览0WOS引用

Joint Final Report of EORTC 26951 and RTOG 9402: Phase III Trials With Procarbazine, Lomustine, and Vincristine Chemotherapy for Anaplastic Oligodendroglial Tumors

Andrew B. Lassman,Khe Hoang-Xuan,Mei-Yin C. Polley,Alba A. Brandes,J. Gregory Cairncross,Johan M. Kros,Lynn S. Ashby,Martin J. B. Taphoorn,Luis Souhami,Winand N. M. Dinjens,Nadia N. Laack,Mathilde C. M. Kouwenhoven,

Journal of clinical oncology（2022）

引用20浏览0WOS引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn